205 related articles for article (PubMed ID: 25380521)
1. MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.
Wagner A; Mayr C; Bach D; Illig R; Plaetzer K; Berr F; Pichler M; Neureiter D; Kiesslich T
Int J Mol Sci; 2014 Nov; 15(11):20134-57. PubMed ID: 25380521
[TBL] [Abstract][Full Text] [Related]
2. Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.
Urbas R; Mayr C; Klieser E; Fuereder J; Bach D; Stättner S; Primavesi F; Jaeger T; Stanzer S; Ress AL; Löffelberger M; Wagner A; Berr F; Ritter M; Pichler M; Neureiter D; Kiesslich T
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941621
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis-related microRNA-145-5p enhances the effects of pheophorbide a-based photodynamic therapy in oral cancer.
Moon S; Kim DK; Kim J
Oncotarget; 2017 May; 8(21):35184-35192. PubMed ID: 28456786
[TBL] [Abstract][Full Text] [Related]
4. Uptake and phototoxicity of meso-tetrahydroxyphenyl chlorine are highly variable in human biliary tract cancer cell lines and correlate with markers of differentiation and proliferation.
Kiesslich T; Neureiter D; Alinger B; Jansky GL; Berlanda J; Mkrtchyan V; Ocker M; Plaetzer K; Berr F
Photochem Photobiol Sci; 2010 May; 9(5):734-43. PubMed ID: 20358123
[TBL] [Abstract][Full Text] [Related]
5. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines.
Kiesslich T; Berlanda J; Plaetzer K; Krammer B; Berr F
Photochem Photobiol Sci; 2007 Jun; 6(6):619-27. PubMed ID: 17549263
[TBL] [Abstract][Full Text] [Related]
6. FosPeg® PDT alters the EBV miRNAs and LMP1 protein expression in EBV positive nasopharyngeal carcinoma cells.
Wu RW; Chu ES; Huang Z; Xu CS; Ip CW; Yow CM
J Photochem Photobiol B; 2013 Oct; 127():114-22. PubMed ID: 24013466
[TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial of temoporfin photodynamic therapy plus chemotherapy in nonresectable biliary carcinoma--PCS Nordic study.
Hauge T; Hauge PW; Warloe T; Drolsum A; Johansen C; Viktil E; Aabakken L; Buanes T; Konopski Z
Photodiagnosis Photodyn Ther; 2016 Mar; 13():330-333. PubMed ID: 26415549
[TBL] [Abstract][Full Text] [Related]
8. Active Wnt signalling is associated with low differentiation and high proliferation in human biliary tract cancer in vitro and in vivo and is sensitive to pharmacological inhibition.
Kiesslich T; Alinger B; Wolkersdörfer GW; Ocker M; Neureiter D; Berr F
Int J Oncol; 2010 Jan; 36(1):49-58. PubMed ID: 19956832
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of alterations in the miRNome in response to photodynamic treatment.
Bach D; Fuereder J; Karbiener M; Scheideler M; Ress AL; Neureiter D; Kemmerling R; Dietze O; Wiederstein M; Berr F; Plaetzer K; Kiesslich T; Pichler M
J Photochem Photobiol B; 2013 Mar; 120():74-81. PubMed ID: 23466801
[TBL] [Abstract][Full Text] [Related]
10. Comparative characterization of the cellular uptake and photodynamic efficiency of Foscan® and Fospeg in a human prostate cancer cell line.
Petri A; Yova D; Alexandratou E; Kyriazi M; Rallis M
Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):344-54. PubMed ID: 23200016
[TBL] [Abstract][Full Text] [Related]
11. Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study.
Wagner A; Denzer UW; Neureiter D; Kiesslich T; Puespoeck A; Rauws EA; Emmanuel K; Degenhardt N; Frick U; Beuers U; Lohse AW; Berr F; Wolkersdörfer GW
Hepatology; 2015 Nov; 62(5):1456-65. PubMed ID: 25990106
[TBL] [Abstract][Full Text] [Related]
12. Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer.
Zuo M; Rashid A; Churi C; Vauthey JN; Chang P; Li Y; Hung MC; Li D; Javle M
Br J Cancer; 2015 Mar; 112(6):1042-51. PubMed ID: 25742482
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK.
Hopper C; Niziol C; Sidhu M
Oral Oncol; 2004 Apr; 40(4):372-82. PubMed ID: 14969816
[TBL] [Abstract][Full Text] [Related]
14. Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling.
Rijlaarsdam MA; van Agthoven T; Gillis AJ; Patel S; Hayashibara K; Lee KY; Looijenga LH
Andrology; 2015 Jan; 3(1):85-91. PubMed ID: 25382245
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for cholangiocarcinoma using low dose mTHPC (Foscan(®)).
Kniebühler G; Pongratz T; Betz CS; Göke B; Sroka R; Stepp H; Schirra J
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):220-8. PubMed ID: 23993847
[TBL] [Abstract][Full Text] [Related]
16. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines.
Sun Z; Li S; Kaufmann AM; Albers AE
Oncol Rep; 2014 Nov; 32(5):2283-9. PubMed ID: 25175929
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression.
Zhong XY; Yu JH; Zhang WG; Wang ZD; Dong Q; Tai S; Cui YF; Li H
Gene; 2012 Feb; 493(1):44-51. PubMed ID: 22146319
[TBL] [Abstract][Full Text] [Related]
18. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J
Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
[TBL] [Abstract][Full Text] [Related]
20. A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers.
Barbato A; Piscopo F; Salati M; Pollastro C; Evangelista L; Ferrante L; Limongello D; Brillante S; Iuliano A; Reggiani-Bonetti L; Salatiello M; Iaccarino A; Pisapia P; Malapelle U; Troncone G; Indrieri A; Dominici M; Franco B; Carotenuto P
Clin Exp Med; 2024 Apr; 24(1):74. PubMed ID: 38598008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
